文献速递白血病

性格迥异的双胞胎:STAT5B而非STAT5A在BCR/ABL诱导的白血病中起关键作用

Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemia.
PubMed 文献 · Leukemia · 2019-01-24

研究以BCR/ABL为模型系统,比较STAT5A与STAT5B在白血病发生中的作用。缺失STAT5A降低细胞存活与集落形成,缺失STAT5B影响更剧烈;Stat5b-/-白血病细胞疾病起病显著延长,Stat5a-/-细胞则与野生型一样快速致死。RNA测序显示Stat5b-/-细胞中干扰素α/γ特征显著增强,抑制干扰素反应可挽救其集落形成;携带STAT5B突变的白血病患者也观察到干扰素反应下调。数据表明STAT5B是驱动BCR/ABL+白血病的主要STAT5亚型,通过抑制IFN-α/γ促进转化。

要点

  • 缺失STAT5A降低细胞存活和集落形成,缺失STAT5B影响更剧烈。
  • Stat5b-/-白血病细胞起病显著延长,Stat5a-/-细胞与野生型一样快速致死。
  • STAT5B通过抑制IFN-α/γ促进BCR/ABL+白血病发生。

核心结论

  • STAT5B是驱动BCR/ABL+白血病的主要STAT5亚型。
  • STAT5B通过抑制IFN-α/γ实现转化,从而促进白血病发生。
  • 该发现可能有助于解释造血系统肿瘤中STAT5B突变的高频率。

研究设计与样本

  • 以BCR/ABL为模型系统,研究STAT5A或STAT5B对白血病发生的贡献。

主要发现

  • 缺失STAT5A降低细胞存活和集落形成,缺失STAT5B时效应更剧烈。
  • STAT5B缺陷细胞形成BCR/ABL+集落或稳定细胞系的频率低。
  • 罕见演化的Stat5b-/-细胞系较野生型细胞表达更高水平的BCR/ABL癌蛋白。
  • Stat5b-/-白血病细胞诱导的白血病起病显著延长,而Stat5a-/-细胞与野生型一样快速引起致死性疾病。
  • RNA测序显示Stat5b-/-细胞中IFN-α和IFN-γ特征显著增强;抑制IFN反应可挽救Stat5b-/-缺陷细胞的BCR/ABL+集落形成;携带STAT5B突变的白血病患者也观察到IFN反应下调。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Deregulation of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathway is found in cancer with STAT5A/B controlling leukemic cell survival and disease progression. As mutations in STAT5B, but not STAT5A, have been frequently described in hematopoietic tumors, we used BCR/ABL as model systems to investigate the contribution of STAT5A or STAT5B for leukemogenesis. The absence of STAT5A decreased cell survival and colony formation. Even more drastic effects were observed in the absence of STAT5B. STAT5B-deficient cells formed BCR/ABL+ colonies or stable cell lines at low frequency. The rarely evolving Stat5b-/- cell lines expressed enhanced levels of BCR/ABL oncoprotein compared to wild-type cells. In line, Stat5b-/- leukemic cells induced leukemia with a significantly prolonged disease onset, whereas Stat5a-/- cells rapidly caused a fatal disease superimposable to wild-type cells. RNA-sequencing (RNA-seq) profiling revealed a marked enhancement of interferon (IFN)-α and IFN-γ signatures in Stat5b-/- cells. Inhibition of IFN responses rescued BCR/ABL+ colony formation of Stat5b-/--deficient cells. A downregulated IFN response was also observed in patients suffering from leukemia carrying STAT5B mutations. Our data define STAT5B as major STAT5 isoform driving BCR/ABL+ leukemia. STAT5B enables transformation by suppressing IFN-α/γ, thereby facilitating leukemogenesis. Our findings might help explain the high frequency of STAT5B mutations in hematopoietic tumors.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Kollmann S, Grundschober E, Maurer B, et al. Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemia. Leukemia. 2019. PMID: 30679796. doi:10.1038/s41375-018-0369-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。